Eiger Gets OK On Ch. 11 Drug Sale After Tripling Initial Bid
By Alex Wittenberg · June 26, 2024, 8:47 PM EDT
A Texas bankruptcy judge on Wednesday approved Eiger BioPharmaceuticals' $35.1 million sale of its Avexitide product, after the drug company more than tripled an initial bid for the metabolic-disease treatment during...
To view the full article, register now.